Astrana Health PE ratio ASTH

Share price divided by earnings per share over the last twelve months, since 2019.

Today, Oct 23, 2026: 45.7×
8-year median: 35.1×
Against its 8-year history: 65th; percentile: 0 is its lowest day, 100 its highest
8-year range: 18.2× to 190×
Peer median: 19.5×

Astrana Health's PE ratio is 45.7× as of Oct 23, 2026: a share price of $37.45 against $0.82 of earnings per share over the last twelve months.

That is above its 8-year median of 35.1×, higher than on 65% of days in the last 8 years.

Over that time it ranged from 18.2× in Dec 2020 to 190× in Dec 2019.

The median for 9 consulting Services stocks of a similar size is 19.5×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	45.7×	41.9×	150×
2025	134×	19.5×	134×
2024	25.2×	25.2×	43.0×
2023	40.3×	20.0×	40.3×
2022	20.8×	19.7×	38.2×
2021	46.5×	22.3×	94.0×
2020	19.0×	18.2×	188×
2019	187×	60.8×	190×

Against its peers

Companies in Consulting Services nearest Astrana Health's size, closest first, today.

Company	PE ratio
ASTHAstrana Health	45.7×
ICFIICF International	19.5×
HURNHuron Consulting	29.3×
EXPOExponent	34.7×
FCNFTI Consulting	19.0×
BWMNBowman Consulting	107×
GGenpact LTD	12.1×
BAHBooz Allen Hamilton	12.3×
HCKTHackett	18.9×
IIIInformation Services	26.9×
Peer median	19.5×

Where Astrana Health ranks

#12of 13Consulting Services stocks with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Astrana Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.